1. Home
  2. |Insights
  3. |PODCAST: U.S. Objectives for Negotiating NAFTA — C&M's Trump: The First Year Series

PODCAST: U.S. Objectives for Negotiating NAFTA — C&M's Trump: The First Year Series

Client Alert | 1 min read | 07.28.17

The U.S. released its negotiating objectives for NAFTA on July 17. In the latest podcast for Crowell & Moring’s “Trump: The First Year” series, Robert Holleyman and John Brew, both partners in the firm’s International Trade Group, discuss the objectives and the key takeaways. Robert previously served as Deputy U.S. Trade Representative and as a counsel for the U.S. Senate. John’s practice focuses on customs, and he has extensive experience in import and export trade regulation.

 Discussed in this 17-minute podcast: 

  • An overview of NAFTA.
  • What the U.S. hopes to accomplish in areas such as trade in goods, digital trade, intellectual property, procurement, currency and others.
  • The high stakes around the rules of origin and how revisions may impact the region.
  • How trade remedies will play into NAFTA and what the fate of Chapter 19 dispute resolution might look like.
  • What businesses with operations or trade interests in Mexico and Canada should do now.

Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes

Contacts

Insights

Client Alert | 4 min read | 01.07.26

FDA Request for Information Signals New Path for VC Firms and their Portfolio Companies in Federal Contracting

On December 17, 2025, the U.S. Food and Drug Administration (FDA) issued a request for information (RFI) on a proposal designed to help the FDA engage more directly with innovative, venture-backed companies focused on biotechnology, medical devices, AI, and regulatory technology.[i]The RFI includes 19 questions, with responses due by 2:00 p.m. ET on January 18, 2026....